Compound Detail
CHEMBL5419985
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@H](C#N)C[C@@H]1CCNC1=O
Basic Information
| ChEMBL ID | CHEMBL5419985 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VGULVEAJHVXHOO-KBCNZALWSA-N |
3
Targets
3
Activities
2
Assay Types
16
PK Parameters
4
Publications
0
Known Names
Molecular Properties
499.5
MW (Da)
1.24
ALogP
5
HBA
3
HBD
131.4
PSA (Ų)
0.51
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 7.19
IC50 1 meas. best 7.37
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Replicase polyprotein 1ab CHEMBL4523582 | IC50 | 7.37 | 7.37 | 43.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 7.19 | 7.19 | 64.0 | 1 |
| Human coronavirus OC43 CHEMBL5209665 | EC50 | 6.87 | 6.87 | 136.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 276.24 | ng.hr.mL-1 | Mus musculus |
| AUC | 1153.91 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 262.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 17.3 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 435.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 32.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 17.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 79.3 | mL.min-1.kg-1 | Mus musculus |
| CL | 75.4 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 790.0 | nM | Mus musculus |
| Cmax | 2980.0 | nM | Rattus norvegicus |
| F | 13.3 | % | Mus musculus |
| F | 52.0 | % | Rattus norvegicus |
| T1/2 | 0.111 | hr | Mus musculus |
| T1/2 | 0.239 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Replicase polyprotein 1ab | IC50 | = | 43.0 | nM | 7.37 | Inhibition of SARS CoV-2 main protease preincubated for 30 min followed by subst... | 37182612 |
| SARS-CoV-2 | EC50 | = | 64.0 | nM | 7.19 | Antiviral activity against SARS-CoV-2 infected in human Vero cells assessed as r... | 37182612 |
| Human coronavirus OC43 | EC50 | = | 136.0 | nM | 6.87 | Antiviral activity against HCoV-OC43 infected in human MRC5 cells assessed as re... | 37182612 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37182612 | 10.1016/j.bmcl.2023.129324 | ADMET | 21 |
| 37182612 | 10.1016/j.bmcl.2023.129324 | Replicase polyprotein 1ab | 1 |
| 37182612 | 10.1016/j.bmcl.2023.129324 | Human coronavirus OC43 | 1 |
| 37182612 | 10.1016/j.bmcl.2023.129324 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine